Spring, L. M., Zangardi, M. L., Moy, B., & Bardia, A. (2017). Clinical Management of Potential Toxicities and Drug Interactions Related to Cyclin‐Dependent Kinase 4/6 Inhibitors in Breast Cancer: Practical Considerations and Recommendations. Oncologist.
Citación estilo ChicagoSpring, Laura M., Mark L. Zangardi, Beverly Moy, y Aditya Bardia. "Clinical Management of Potential Toxicities and Drug Interactions Related to Cyclin‐Dependent Kinase 4/6 Inhibitors in Breast Cancer: Practical Considerations and Recommendations." Oncologist 2017.
Cita MLASpring, Laura M., Mark L. Zangardi, Beverly Moy, y Aditya Bardia. "Clinical Management of Potential Toxicities and Drug Interactions Related to Cyclin‐Dependent Kinase 4/6 Inhibitors in Breast Cancer: Practical Considerations and Recommendations." Oncologist 2017.